๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Chemotherapy of nonirradiated malignant gliomas. Phase II: Study of the combination of methyl-CCNU, vincristine, and procarbazine

โœ Scribed by Anthony M. Avellanosa; Charles R. West; Yoshiaki Tsukada; Donald J. Higby; Surag Bakshi; Peter A. Reese; E. Jennings

Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
1019 KB
Volume
44
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Efficacy and feasibility of standard pro
Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy : A phase II study
โœ Alba Ariela Brandes; Alicia Tosoni; Francesca Vastola; Lara Maria Pasetto; Barto ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 93 KB

## Abstract ## BACKGROUND To the authors' knowledge, there is a scarcity of accurate data regarding the feasibility of standard chemotherapy with procarbazine, lomustine, and vincristine (PCV) in a homogeneous series of patients with primary anaplastic oligodendroglioma (AO) and oligoastrocytoma (

A phase II study of intravenously-admini
A phase II study of intravenously-administered methyl CCNU in the treatment of advanced sarcomas
โœ Paul Chang; Marshall A. Levine; Peter H. Wiernik; Michael D. Walker ๐Ÿ“‚ Article ๐Ÿ“… 1976 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 392 KB ๐Ÿ‘ 2 views

Thirty-two patients with advanced, inoperable nonhematologic soft-tissue and osseous sarcomas were treated with Methyl CCNU administered via controlled intravenous infusion in doses of 130-170 mg/m2 every 6 weeks in a Phase I1 trial. All 28 evaluable patients were no longer responsive to adriamycin.